XML 58 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | The following table illustrates information about segment revenues, significant segment expenses, and segment net income (loss) for the three and nine months ended September 30, 2025 and 2024 (in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Revenues | $ | 159,395 |  |  | $ | 117,085 |  |  | $ | 468,282 |  |  | $ | 319,178 |
Less 1: |  |  |  |  |  |  |
Cost of product sales | 2,187 |  |  | 3,211 |  |  | 9,553 |  |  | 6,175 |
Research and development |  |  |  |  |  |  |
Berotralstat | 2,575 |  |  | 2,954 |  |  | 9,214 |  |  | 10,504 |
BCX17725 | 7,574 |  |  | 1,154 |  |  | 13,346 |  |  | 6,591 |
Avoralstat | 1,800 |  |  | 2,104 |  |  | 7,584 |  |  | 4,960 |
Factor D Program | 35 |  |  | 1,193 |  |  | 454 |  |  | 7,299 |
Research, discovery and preclinical programs | 5,457 |  |  | 3,309 |  |  | 11,641 |  |  | 8,325 |
Compensation and related personnel costs | 13,313 |  |  | 14,257 |  |  | 38,025 |  |  | 42,630 |
Stock-based compensation | 6,520 |  |  | 8,530 |  |  | 24,374 |  |  | 20,923 |
Other non-program specific and indirect costs | 7,329 |  |  | 7,580 |  |  | 20,621 |  |  | 23,965 |
Selling, general and administrative | 83,014 |  |  | 65,101 |  |  | 252,866 |  |  | 185,841 |
Interest income | (2,238) |  |  | (3,591) |  |  | (7,778) |  |  | (11,176) |
Interest expense | 19,661 |  |  | 24,828 |  |  | 64,737 |  |  | 74,067 |
Foreign currency (gains) losses, net | (35) |  |  | (98) |  |  | 27 |  |  | 37 |
Loss on extinguishment of debt | 2,740 |  |  | — |  |  | 6,911 |  |  | — |
Other income | (2,667) |  |  | — |  |  | (2,667) |  |  | — |
Income tax (benefit) expense | (769) |  |  | 586 |  |  | 1,358 |  |  | 1,123 |
Segment net income (loss) | 12,899 |  |  | (14,033) |  |  | 18,016 |  |  | (62,086) |
Reconciliation of segment profit or loss: |  |  |  |  |  |  |
Adjustments and reconciling items | — |  |  | — |  |  | — |  |  | — |
Consolidated net income (loss) | $ | 12,899 |  |  | $ | (14,033) |  |  | $ | 18,016 |  |  | $ | (62,086) |
1 The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration